4D Molecular Therapeutics Company
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
Headquarters:
Emeryville, California, United States
Last Funding Type:
Series C
Investors Number:
20
Last Funding Date:
2020
Employee Number:
11-50
Total Funding:
174999995
Founded Date:
2013
Estimated Revenue:
$10M to $50M
Investor Type:
IPO
Industry:
Biotechnology, Genetics